China Making Its Mark in Global Biopharma Patent Filings

Innovation is on the rise in China's Biotech and Pharma sectors, according to a survey of patent filings and patent approvals conducted by Thomson Reuters. Of all the institutions/ companies filing patents globally in 2014, China is home to three of the top five Biotech filing institutions and two of the top five Pharma filing entities. Globally, the number of filings/approvals climbed just 3% last year in all sectors. The Biotech and Pharma sectors, however, are much stronger than the overall average, and the difference seems to have been China's rising contribution. More details.... Share this with colleagues: // //